Insulin Resistance and Risk of Incident Cardiovascular Events in Adults without Diabetes: Meta-Analysis
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Glucose, insulin and Homeostasis Model Assessment Insulin Resistance (HOMA-IR) are markers of insulin resistance. The objective of this study is to compare fasting glucose, fasting insulin concentrations and HOMA-IR in strength of association with incident cardiovascular disease. METHODS: We searched the PubMed, MEDLINE, EMBASE, Web of Science, ScienceDirect and Cochrane Library databases from inception to March, 2011, and screened reference lists. Cohort studies or nested case-control studies that investigated the association between fasting glucose, fasting insulin or HOMA-IR and incident cardiovascular disease, were eligible. Two investigators independently performed the article selection, data extraction and risk of bias assessment. Cardiovascular endpoints were coronary heart disease (CHD), stroke or combined cardiovascular disease. We used fixed and random-effect meta-analyses to calculate the pooled relative risk for CHD, stroke and combined cardiovascular disease, comparing high to low concentrations of glucose, insulin or HOMA-IR. Study heterogeneity was calculated with the I(2) statistic. To enable a comparison between cardiovascular disease risks for glucose, insulin and HOMA-IR, we calculated pooled relative risks per increase of one standard deviation. RESULTS: We included 65 studies (involving 516,325 participants) in this meta-analysis. In a random-effect meta-analysis the pooled relative risk of CHD (95% CI; I(2)) comparing high to low concentrations was 1.52 (1.31, 1.76; 62.4%) for glucose, 1.12 (0.92, 1.37; 41.0%) for insulin and 1.64 (1.35, 2.00; 0%) for HOMA-IR. The pooled relative risk of CHD per one standard deviation increase was 1.21 (1.13, 1.30; 64.9%) for glucose, 1.04 (0.96, 1.12; 43.0%) for insulin and 1.46 (1.26, 1.69; 0.0%) for HOMA-IR. CONCLUSIONS: The relative risk of cardiovascular disease was higher for an increase of one standard deviation in HOMA-IR compared to an increase of one standard deviation in fasting glucose or fasting insulin concentration. It may be useful to add HOMA-IR to a cardiovascular risk prediction model.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Both prediabetes and metabolic syndrome confer increased risk of T2D and CVD.802–804”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [803]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, a meta-analysis of the association between Homeostasis Model Assessment Insulin Resistance (HOMA-IR) and cardiovascular events used dose-response modelling to estimate that the cardiovascular risk increased by 46% per one standard deviation increase in HOMA-IR [24].”
From COSMOS-E: Guidance on conducting systematic reviews and meta-analyses of observational studies of etiology (2019) · cites this paper as [24]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In observational studies, a reduction in HOMA-IR was also associated with a reduction in CRP 81 and cardiovascular risk. 82”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040
Ogurtsova, K., da Rocha Fernandes, J. D., Huang, Y., Linnenkamp, U., Guariguata, L., Cho, N. H., Cavan, D., Shaw, J. E., & Makaroff, L. E. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.03.024 · Cited by 6,966
Oxidative stress and diabetic complications
Giacco, F., & Brownlee, M. (2010) · Circulation Research · doi:10.1161/circresaha.110.223545 · Cited by 5,461
The Emerging Risk Factors Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)60484-9 · Cited by 5,125
Use and Abuse of HOMA Modeling
Wallace, T. M., Levy, J. C., & Matthews, D. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1487 · Cited by 5,114 · cited 2×
“Finally, we only included studies that measured HOMA-IR, which is a surrogate measure of insulin resistance and mainly reflects hepatic insulin resistance [12].”
BackgroundMethodIDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030
Whiting, D. R., Guariguata, L., Weil, C., & Shaw, J. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.10.029 · Cited by 3,994
Tunstall-Pedoe, H., Kuulasmaa, K., Amouyel, P., Arveiler, D., Rajakangas, A. M., & Pajak, A. (1994) · Circulation · doi:10.1161/01.cir.90.1.583 · Cited by 2,263
Huxley, R., Barzi, F., & Woodward, M. (2006) · BMJ · doi:10.1136/bmj.38678.389583.7c · Cited by 1,534
Insulin Resistance, Hyperglycemia, and Atherosclerosis
Bornfeldt, K. E., & Tabas, I. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.07.015 · Cited by 995
(1995) · The Lancet · doi:10.1016/s0140-6736(95)92836-7 · Cited by 856
Research works printed but not linked: 1
- Rothman KJ, Greenland S, Lash TL (2008) Modern Epidemiology. Lippincott Williams & Wilkins. 112 p.
Cited by
Items 301–400 of 402
Lee, A.-N., Koh, H.-M., Jang, J.-Y., Bak, H.-R., Jang, H.-J., Huh, J.-Y., & Ko, N. G. (2024) · Korean Journal of Family Medicine · doi:10.4082/kjfm.23.0108 · Cited by 2
“The study findings showed that the group with CAC progression had Insulin resistance is a substantial risk factor for ASCVD [26], and the TyG index is a reliable surrogate marker for insulin resistance [27].”
Dales, R., Lukina, A. O., & Cakmak, S. (2024) · Environmental Research · doi:10.1016/j.envres.2024.119417 · Cited by 2
Wang, J., Xu, C., & Song, Q. (2015) · Energy & Fuels · doi:10.1021/ef502484f · Cited by 2
Ting, K. K. Y. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1407108 · Cited by 2
“Long-term excess hepatic fructose metabolism can also induce insulin resistance (85–87), which is another strong predictor of atherosclerosis (88–90), specifically inducing hepatic insulin resistance prior to whole body insulin resistance (91, 92).”
BackgroundRepo, O., Juonala, M., Rovio, S., Mykkänen, J., Nevalainen, J., Kähönen, M. A. P., Lehtimäki, T. J., Laitinen, T. P., Viikari, J., Raitakari, O. T., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae865 · Cited by 1
A systems engineering approach to coronary heart disease
Mathews, M. J. (2015) · Cited by 2
Admission glucose as a prognostic marker for all-cause mortality and cardiovascular diseasePreprint
Djupsjö, C., Kuhl, J., Andersson, T., Lundbäck, M., Holzmann, M. J., & Nyström, T. (2022) · Research Square · doi:10.21203/rs.3.rs-1715964/v1 · Cited by 2
Antenatal Glycemic Management and Postpartum Cardiovascular Disease Risk Screening
Essington, R., Pudwell, J., Retnakaran, R. R., & Smith, G. N. (2024) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2024.102561 · Cited by 1
Anyiam, O., & IDRIS, I. R. (2025) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2025.2527791 · Cited by 1
“IR and impaired BCF play a crucial role in the pathogenesis of T2D [11,33], whilst individuals without T2D are also prone to IR [7,8], which in itself is independently associated with poor health outcomes [34,35].”
Chen, X., Wang, L., Li, Z., Xu, G., Zhang, N., & Du, D. (2025) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2025.07.014 · Cited by 1
Ebrahimi, N., Masrouri, S., Zadeh, S. S. T., Tohidi, M., Azizi, F., & Hadaegh, F. (2025) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2025.101353 · Cited by 1
“In the aforementioned meta-analysis by Gast et al., elevated insulin levels were significantly associated with CVD risk in women but not in men, while HOMA-IR showed a significant association with CVD in both sexes [21].”
InfluentialKiyohara, T., Nakamura, K., Irie, F., Wakisaka, Y., Matsuo, R., Kamouchi, M., Ago, T., & Investigators for Fukuoka Stroke Registry (2026) · Journal of the American Heart Association · doi:10.1161/jaha.125.045867 · Cited by 1
Facteurs de risque et maladies chroniques : le diabète en exemple
Schlienger, J.-L., Monnier, L., Essekkat, N., Azrak, A. E., Raji, F., & Rochd, D. (2019) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(19)30019-7 · Cited by 4
Siswanto, A., Juffrie, M., Rianto, B. U. D., & Asdie, H. A. H. (2020) · Journal of the Medical Sciences (Berkala Ilmu Kedokteran) · doi:10.19106/jmedsci005201202008 · Cited by 1
Early Renal Dysfunction in Obese Patients with Insulin Resistance
Перцева, Н. О., & Рокутова, М. К. (2019) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.2478/rjdnmd-2019-0027 · Cited by 1
Kotova, J., Зуйкова, А. А., Pashkov, A., Strahova, N. V., Krasnorutskaya, O. N., Shevzova, V., & Есина, Е. Ю. (2020) · International Journal of Biomedicine · doi:10.21103/article10(2)_oa2 · Cited by 1
Diabetes and coronary circulation: From pathology to imaging
Henein, M. Y., Vancheri, S., & Vancheri, F. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817428-9.00008-5 · Cited by 1
Alimentación en tiempo restringido: Efectos cardiometabólicos en adultos con exceso de peso
Bórquez, J. C., Yáñez-Barros, E., Carrera-Gil, F., & Briones, L. (2022) · Revista chilena de nutrición · doi:10.4067/s0717-75182022000500486 · Cited by 5
Bezdenezhnykh, N. A., Sumin, A. N., Bezdenezhnykh, A. V., Sinitskaya, А. V., Kuzmina, A. A., Koshelev, V. A., Briukhanov, Y. I., Фокин, Ф. А., & Барбараш, О. Л. (2023) · Complex Issues of Cardiovascular Diseases · doi:10.17802/2306-1278-2022-11-4s-6-24 · Cited by 1
Muntari, J., Umar, H., Tandean, P., Bakri, S., Sanusi, H. D., Tabri, N. A., & Seweng, A. (2023) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.038.01.03 · Cited by 1
Liu, Q., Hu, F., Zeng, J., Ma, L., Yan, S., Li, C., Tian, H., & Gong, Y. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e14100 · Cited by 2
Elgendy, D. S., & Salman, M. M. (2023) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2023.294162 · Cited by 1
Research Progress on Triglycerides-Glucose Body Mass Index
曹, 亮. (2024) · Journal of Clinical Personalized Medicine · doi:10.12677/jcpm.2024.34279 · Cited by 1
Bondar', I. A., & Шабельникова, О. Ю. (2025) · Vrach · doi:10.29296/25877305-2025-03-12 · Cited by 1
Mechanisms of Diabetic Atherosclerosis
Paneni, F., & Cosentino, F. (2015) · Springer eBooks · doi:10.1007/978-3-319-17762-5_3 · Cited by 1
Type 2 Diabetes and the Reduction of Cardiovascular Risk: Sorting Out the Actors and the Roles
Feldman, R. D., FITCHETT, D. H., Hegele, R. A., & Poulter, N. R. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2018.01.091 · Cited by 1
Atherosclerosis is a vascular stem cell disease caused by insulin
Traunmüller, F. (2018) · Medical Hypotheses · doi:10.1016/j.mehy.2018.03.011 · Cited by 2
Cheng, F., & Zhang, J. (2020) · Springer eBooks · doi:10.1007/978-981-15-5975-4_8 · Cited by 1
Risco de Farmingham e evento cardiovascular em mulheres com síndrome dos ovários policísticos
Santos, A. G. (2014) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Sezer, S. D. (2019) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2019.360 · Cited by 1
Liu, C., Zhao, Q., Ma, X., Cheng, Y., Sun, Y., Zhang, D., Liu, X., & Zhou, Y. (2022) · Research Square · doi:10.21203/rs.3.rs-1673524/v2 · Cited by 1
Curcumin Extract Diminishes Atherogenic Risk in Type 2 Diabetes Mellitus Patients With ObesityPreprint
Yaikwawong, M., Jansarikit, L., Jirawatnotai, S., & Chuengsamarn, S. (2024) · medRxiv · doi:10.1101/2024.05.30.24308243 · Cited by 1
DIAVIP - Diabetes Prevention in Primary Care - Implications for Physical Activity
Hellgren, M. I. (2014) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Ahuja, V. (2015) · D-Scholarship@Pitt (University of Pittsburgh)
Balkheyour, A., Ashour, O., Abualhamael, S. A., Aziz, S., & Alsini, H. (2017) · International Journal of Advanced Research · doi:10.21474/ijar01/4224
“In turn, insulin resistance is an important risk factor for cardiovascular disease and increased morbidity and mortality in the general population [23].”
BackgroundEffets cardio-métaboliques des glucides
Amouyal, C., Mosbah, H., & Andréelli, F. (2018) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(18)30115-9
APO B/APO A-I RATIO IN PATIENTS WITH STENOSIS CORONARY HEART DISEASE GREATER OR LESS THAN 70%
Ansyari, D., Tambunan, T., & Hasan, H. (2018) · INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY · doi:10.24293/ijcpml.v23i3.1198
Bolotskykh, A. V., Rudyk, I. S., & Pyvovar, S. M. (2014) · Clinical pharmacy · doi:10.24959/cphj.14.1314
Mahdavi, S. S. (2018) · TSpace (University of Toronto)
Nokoff, N., Scarbro, S. L., Moreau, K. L., Zeitler, P. S., Nadeau, K. J., Juarez‐Colunga, E., & Kelsey, M. M. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/603019
“In adults, worse insulin resistance is associated with incident coronary heart disease, which has been shown to be more common among transgender than cisgender adults (5,29).”
BackgroundCorrelation between Body Mass Index and Homa Index in Bariatric Patients
Dejeu, P., Dejeu, V., Dejeu, D., & Bembea, M. (2019) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.2478/rjdnmd-2019-0004
Insulin resistance and heart disease
Farooqui, A. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819603-8.00003-1
Bariatric surgery metabolic effects in obese individuals associating insulin resistance status
Dejeu, P., Dejeu, V., & Bembea, M. (2019) · Romanian Medical Journal · doi:10.37897/rmj.2019.4.19
Insulin resistance and associated factors in healthy volunteers in South-west Nigeria
Adejumo, E., Adejumo, O., & Ogundahunsi, O. (2020) · Annals of Health Research (The Journal of the Medical and Dental Consultants Association of Nigeria OOUTH Sagamu Nigeria) · doi:10.30442/ahr.0602-03-76
Emerging biomarkers in cardiometabolic disease
Molvin, J. (2020) · Lund University Publications (Lund University)
Ng, Y. V. (2020) · Universiti Sains Malaysia Institutional Repository (Universiti Sains Malaysia)
The effect of syndrome X on the development of cardiovascular pathology (review of literature)
Chupakha, M. V., Белоусова, О. Н., & Kochinova, E. A. (2020) · Актуальные проблемы медицины · doi:10.18413/2687-0940-2020-43-4-498-508
Özkur, E., Erdem, Y., Altunay, İ. K., Demіr, D., Dolu, N. Ç., Serin, E., & Çerman, A. A. (2020) · Anais Brasileiros de Dermatologia · doi:10.1016/j.abdp.2020.04.007
Zhai, G., Zhang, B., Wang, J., Liu, Y., & Zhou, Y. (2021) · Research Square · doi:10.21203/rs.3.rs-819706/v1
Physical activity and cardiovascular disease risk in women with polycystic ovary syndrome
Woodward, A. (2021) · Sheffield Hallam University · doi:10.7190/shu-thesis-00398 · Cited by 2
Yoon, J. S., Shim, Y. S., Lee, H. S., Hwang, I. T., & Hwang, J. S. (2021) · Research Square · doi:10.21203/rs.3.rs-721138/v1
Saikia, D., & Kumar, S. (2022) · Medical Hypotheses · doi:10.1016/j.mehy.2022.110804
Liu, C., Zhao, Q., Ma, X., Cheng, Y., Sun, Y., Zhang, D., Liu, X., & Zhou, Y. (2022) · Research Square · doi:10.21203/rs.3.rs-1555190/v1
Anne, V. R. M. (2020) · Research Publications (Maastricht University) · doi:10.26481/dis.20200701mr
Insulin Resistance, Body Mass Index and Coronary Atherosclerotic Stenosis in Obese AdultsPreprint
Zhang, N., Liu, Y., Yang, G., Zhou, B., Qi, G., Yu, J., Yan, Z., Liu, H., & Meng, H. (2020) · doi:10.21203/rs.3.rs-28915/v1
“An meta-analysis of 65 studies published in 2012, which included 516,325 participants, also revealed that insulin resistance, evaluated by HOMA-IR, was a good predictor for cardiovascular disease[8].”
MethodCardiovascular disease in cancer survivors: Risk and management
Khan, S. N., & Neyaz, M. K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90461-2.00003-1
Liu, C., Liu, X., Ma, X., Cheng, Y., Sun, Y., Zhang, D., Zhao, Q., & Zhou, Y. (2022) · Research Square · doi:10.21203/rs.3.rs-1881958/v1
Liu, C., Zhao, Q., Ma, X., Cheng, Y., Sun, Y., Zhang, D., Liu, X., & Zhou, Y. (2022) · Research Square · doi:10.21203/rs.3.rs-1673524/v1
Manaserh, I. H., Bledzka, K. M., Junker, A., Grondolsky, J., & Schumacher, S. M. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4351882
Manaserh, I. H., Bledzka, K. M., Junker, A., Grondolsky, J., & Schumacher, S. M. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4352390
Manaserh, I. H., Bledzka, K. M., Junker, A., Grondolsky, J., & Schumacher, S. M. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4351453
Aktaş, H., Gül, M., İnci, S., Yıldırım, O., & Turgut, M. S. (2023) · Journal of Investigative Medicine · doi:10.1177/10815589231158040
Review article: Type 2 diabetes mellitus: Pathogenesis and therapeutic intervention
Albajy, M. A., Mihailescu, D. F., Nawfal, A. S., & Mohammed, J. A. (2023) · AIP conference proceedings · doi:10.1063/5.0112591
Medrano, M., Garrido‐Miguel, M., Martínez-Ortega, I. A., Mesas, A. E., Amaro‐Gahete, F. J., Martínez‐Vizcaíno, V., & Fernández‐Rodríguez, R. (2023) · Physiology & Behavior · doi:10.1016/j.physbeh.2023.114332
Phan, T.-P., Nguyen, P., Vo, T. H., Hsu, M., Saputra, Y. E., Hien, N. T., Chen, C., Le, K. M., Nguyen, H. B., & Hsu, J. C. (2023) · Research Square · doi:10.21203/rs.3.rs-3311009/v1
Hao, C., Lei, Z., Zhang, J., Hu, Q., Guo, F., Mo, Z., Huang, B., & Liu, C. (2023) · Research Square · doi:10.21203/rs.3.rs-3447796/v1
Cardiovascular Consequences of Metabolic Disturbances in Women
Turan, B. (2023) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-39928-2_26
Diabetes, Prediabetes, Metabolic Syndrome, and Large Artery Vascular Ageing
Stehouwer, C. D. A., van der Heide, F. C. T., Kozàkovà, M., & Palombo, C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15512-3.00007-6
Larsson, J., Auscher, S., Pararajasingam, G., Heinsen, L. J., Andersen, T. R., Lambrechtsen, J., & Egstrup, K. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.117524
Zhao, G., Shang, S., Tian, N., Zhan, X., Peng, F., Wang, X., Wen, Y., Xu, Q., Feng, X., Tang, X., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4193924/v1
Butts, B. (2024) · Springer eBooks · doi:10.1007/978-3-031-53705-9_3
Zhang, M., Gao, Y., Hu, F., & Cai, Y. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4878505
Mendoza‐Marí, Y., Wilson, V. E. D., Wilson, D. R., & Agrawal, D. K. (2024) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-62806-1_23
蒲, 高. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.14102623
Larsson, J., Lambrechtsen, J., Auscher, S., Shamoun, A., Pararajasingam, G., Heinsen, L. J., Andersen, T. R., Lindholt, J. S., Diederichsen, A. C. P., & Egstrup, K. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.5030726
Hummady, S. A., & Algenabi, A. H. A. (2024) · Kufa Medical Journal · doi:10.36330/kmj.v20i2.17567
Tong, Z., Hu, M., Cai, Z., Li, S., & Yang, D. (2024) · Research Square · doi:10.21203/rs.3.rs-5418238/v1 · Cited by 2
Guo, X., Chu, H., Xu, H., Guo, Z., Tian, Y., & Gao, L. (2025) · Research Square · doi:10.21203/rs.3.rs-5803162/v1
Investigating the shared genetic architecture between type 2 diabetes and strokePreprint
Islam, T., Zeng, J., & Moni, M. A. (2025) · medRxiv · doi:10.1101/2025.03.24.25324577
Guo, S.-H., Xu, J., Gong, Y.-Q., Hu, W., Li, C., & Lü, K. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1574238
“Meta-analyses and extensive research have consistently highlighted the strong association between IR and atherosclerotic CVD (34 – 37).”
Metabolic Risk Factors in NonCVD Individuals and Their Trajectory Toward Cardiovascular IncidencePreprint
Mahdavi, M., Kazemnejad, A., Asosheh, A., & Khalili, D. (2025) · Research Square · doi:10.21203/rs.3.rs-6690336/v1
Yuan, Y., Yu, X., Tao, J., Peng, H., & Yang, Y. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-096869
Hu, Y., Li, X., Li, J., Yu, M., Li, X., & Cui, W. (2025) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2025.104469
Lu, Y.-W., Chang, C.-C., Chou, R.-H., Tsai, Y.-L., Liu, L.-K., Chen, L.-K., Huang, P.-H., & Lin, S.-J. (2021) · Figshare · doi:10.6084/m9.figshare.16807817
Barzegar, N., Tohidi, M., Hasheminia, M., Azizi, F., & Hadaegh, F. (2020) · Figshare · doi:10.6084/m9.figshare.13023776
Djupsjö, C., Kuhl, J., Andersson, T., Lundbäck, M., Holzmann, M. J., & Nyström, T. (2022) · Figshare · doi:10.6084/m9.figshare.21629313
Zhao, Q., Cheng, Y.-J., Xu, Y.-K., Zhao, Z.-W., Liu, C., Sun, T.-N., & Zhou, Y.-J. (2021) · Figshare · doi:10.6084/m9.figshare.16640904
Liu, C., Liu, X., Ma, X., Cheng, Y., Sun, Y., Zhang, D., Zhao, Q., & Zhou, Y. (2022) · Figshare · doi:10.6084/m9.figshare.21293505
Lu, Y.-W., Chang, C.-C., Chou, R.-H., Tsai, Y.-L., Liu, L.-K., Chen, L.-K., Huang, P.-H., & Lin, S.-J. (2021) · Figshare · doi:10.6084/m9.figshare.16807820
Zhang, Z., Zhao, L., Lu, Y., Xiao, Y., & Zhou, X. (2024) · Figshare · doi:10.6084/m9.figshare.26730655
Li, W., Shen, C., Kong, W., Zhou, X., Fan, H., Zhang, Y., Liu, Z., & Zheng, L. (2024) · Figshare · doi:10.6084/m9.figshare.26517820
Zhao, Q., Cheng, Y.-J., Xu, Y.-K., Zhao, Z.-W., Liu, C., Sun, T.-N., & Zhou, Y.-J. (2021) · Figshare · doi:10.6084/m9.figshare.16640907
Binsch, C., Barbosa, D. M., Hansen-Dille, G., Hubert, M., Hodge, S. M., Kolasa, M., Jeruschke, K., Weiß, J., Springer, C. A., Gorressen, S., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22614281
Li, H., Zuo, Y., Qian, F., Chen, S., Tian, X., Wang, P., Li, X., Guo, X., Wu, S., & Wang, A. (2022) · Figshare · doi:10.6084/m9.figshare.20056296
Seyedhoseinpour, A., Barzin, M., Mahdavi, M., Valizadeh, M., Azizi, F., Ghareh, S., & Hosseinpanah, F. (2026) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-026-01867-x · Cited by 2
Xu, J., Ke, C., Qiu, Y., Chen, S., Chen, X., Bi, C., & Zhang, H. (2026) · European journal of medical research · doi:10.1186/s40001-026-04476-9
“Evidence indicates that IR is an independent risk factor for CVD, primarily through its roles in dyslipidemia, endothelial dysfunction, and chronic inflammation [34, 35].”
Sadrinasab, S., Jeddi, S., Azizi, F., & Ghasemi, A. (2026) · Intern J Endocrinol Metab · doi:10.5812/ijem-167774
“Although these parameters are not currently used in clinics for diagnosis or treatment, accumulating evidence indicates their future applicability, particularly in relation to cardiovascular disease in type 2 diabetes (42).”
Abdu, F. A., Mohammed, A., Zhang, W., Alifu, J., Liu, L., Yin, G., Liao, Y., Zhu, G., & Che, W. (2026) · Cardiovascular Diabetology · doi:10.1186/s12933-026-03244-7
“…per-unit significance of HOMA-IR aligns with the primary role of hepatic insulin resistance as the earliest detectable IR defect, which promotes endothelial dysfunction, dyslipidemia, and low-grade inflammation through hepatic glucose overproduction and compensatory hyperinsulinemia [5, 6].”
Mahdavi, M., Kazemnejad, A., Khalili, D., Tajari, A., & Asosheh, A. (2026) · Research Square · doi:10.21203/rs.3.rs-9667716/v1
Tang, C.-C., Tsai, J., Chen, Y.-H., Hung, S., Lin, Y., & Hsu, B.-G. (2026) · Renal Failure · doi:10.1080/0886022x.2026.2692758
“…disrupts the metabolic homeostasis in patients on Pd. iR is a key driver of atherogenesis and cardiovascular disease in the general population [12,13]. although iR worsens as chronic kidney disease (CKd) progresses, it is further exacerbated in the Pd population by continuous exposure to…”
Metadata
- Authors
- Gast, K. B., Tjeerdema, N., Stijnen, T., Smit, J. W. A., & Dekkers, O. M.
- Affiliations
- Leiden University Medical Center (NL)
- Corresponding author
- Gast, Karin B.
- Tjeerdema, Nathanja
- Stijnen, Theo
- Smit, Johannes W. A.
- Dekkers, Olaf M.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-12-28
- Volume
- 7
- Issue
- 12
- Pages
- e52036
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3532497
- OpenAlex
- W2039758398
- Cited by
- 403
- References
- 33
- Citations by year
- 2026: 14 · 2025: 38 · 2024: 60 · 2023: 50 · 2022: 52 · 2021: 40 · 2020: 35 · 2019: 26 · 2018: 17 · 2017: 15 · 2016: 14 · 2015: 19 · 2014: 18 · 2013: 4
- FWCI
- 10.53
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Universiteit Leiden
- Leids Universitair Medisch Centrum
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- insulin resistance, HOMA-IR, fasting blood glucose, fasting insulin, incident cardiovascular disease, coronary artery disease, stroke, cardiovascular risk prediction, non-diabetic adults, risk stratification model, risk reclassification, risk prediction thresholds
- MeSH terms
- Adult, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Humans, Insulin Resistance, Risk Factors, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.